//
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
Heart Failure Outcomes With Volume-Guided Management
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries